July 7, 2020 / 12:27 PM / a month ago

BRIEF-BioCardia Says Submitted Detailed Response FDA Related To Investigational New Drug Application For BCDA-03

July 7 (Reuters) - BioCardia Inc:

* BIOCARDIA INC - SUBMITTED DETAILED RESPONSE FDA RELATED TO INVESTIGATIONAL NEW DRUG APPLICATION FOR BCDA-03

* BIOCARDIA INC - RECEIVED CONFIRMATION THAT FDA RECEIVED SUBMISSION ON JULY 2, 2020. Source: bit.ly/2O1ynpL Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below